Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05862415
Other study ID # 198511
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 10, 2022
Est. completion date April 10, 2023

Study information

Verified date May 2023
Source Princess Nourah Bint Abdulrahman University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It is widely accepted that aerobic exercise and strengthen training are the core components of most workout programs. However, there is no clear consensus on whether the order in which the exercises are performed impacts their effectiveness. Therefore, the overarching aim of the study is to understand the optimal order of two types of concurrent training program for 13 weeks by comparing the effectiveness of the training on body composition, predicated maximal oxygen uptake (MaxVO2), dynamic respiratory parameters, and muscle strength in healthy middle-aged people. Methods:Thirty-three moderately-active middle-aged and healthy participants were randomly assigned to the strength+aerobic group (SAG, n = 16) and aerobic+strength group (ASG, n = 17). Body composition, aerobic endurance, respiratory parameters and upper and lower strength were assessed before (pre-test) and after (post-test) a 13-week intervention. The chi-square test and the independent t-test will be used to compare sociodemographic variables between the groups. A 2 x 2 analysis of variance (ANOVA) with repeated measures (group x measurement) will be conducted. This study will enhance our understanding of the concurrent training effect on muscle composition and strength. These training programs allow for reducing the duration of the training, which can be an important factor in making adults more willing to participate in physical activity.


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date April 10, 2023
Est. primary completion date February 10, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - middle-aged adults ( over the age of 40) - No history of cardiovascular or neuromuscular disorders - not having orthopedic disorder or neurologic disorders. Exclusion Criteria: - adults using artificial prosthesis - participation in any structured training program - any disease that precludes exercise or necessitates special care (for example, coronary artery disease, thrombosis, moderate or severe bone disease, and lung or renal disease)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
therapeutic Exercise
The circular training method was used in the resistance training phase. During the aerobic training phase, a series of movements from moderate intensity to vigorous intensity was performed. The step loading periodization principle was taken into account in both resistance training and aerobic exercises. The RT lasted approximately 20-25 min per session and included two sets of 8-20 repetitions, with a rest interval of 1-2 min. The RT exercises included: squat, barbell bent-over row, overhead press, plank, lateral pull down, triceps push down, barbell curl, leg extension, leg curl, lunge, barbell bench press, crunches etc. For the aerobic training: Intensity was established between 50-65% and 80-85% of HRmax for both groups (SAG and ASG). Aerobic training includes walking and running periods and was carried out on a 400 m outdoor track. In periodization, especially 1st-4th.

Locations

Country Name City State
Saudi Arabia Princess Nourah bint Abdulrahman University Riyadh

Sponsors (1)

Lead Sponsor Collaborator
Monira Aldhahi

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Body fat % To measure the BF%, a bioelectrical impedance analysis was used. The participants will be instructed to stand barefoot on the bioelectrical impedance analysis devices (seca mBCA 515, Hamburg, Germany).The device measures the body composition and includes a platform with handrails and electrodes that measure the impedance passed through the pairs of hands and feet while standing. Impedance was measured over 75 s with a current of 100 µA at a frequency range between 1 kHz and 1000 kHz and a capacity of 360 kg. Waist circumference measurement at the umbilicus and level physical activity level were inputted to indirectly estimate the body composition. 10 min
Primary Predicated maximal oxygen uptake (MaxVO2) 1-mile walk-run performance test was used. The aim of this test is to cover a distance of one mile in the shortest possible time. Participants can alternate between walking and running as desired; however, they should be encouraged to cover the distance as quickly as feasible. The time elapsed to cover a mile distance, measured in minutes and seconds. During the testing and recovery the heart rate of the participants was monitored with a heart rate sensor (Polar Verity Sense; Kempele, Finland). Polar Verity Sense can be connected to a sports watch or app via Bluetooth®, ANT+, and internal memory to instantly track your training or view the data after training. As a result, the participant's time for completing the 1-mile test was tracked using a smart phone GPS system. The validity of the device has previously been reported previously[27]. The participants' MaxVO2 values were calculated using the formulas below. 1 day
Primary Forced Vital Capacity (FVC) a spirometer device (Minispir®, PC-based Spirometer with Oximetry option, Italy) will be used to measure the Forced Vital Capacity (FVC), Forced Expiratory Volume in One Second (FEV1). 1 day
Primary Forced Expiratory Volume in One Second a spirometer device (Minispir®, PC-based Spirometer with Oximetry option, Italy) will be used to measure the Forced Vital Capacity (FVC), Forced Expiratory Volume in One Second (FEV1). 1 day
Primary Grip Strength A handgrip dynamometer was used to measure the strength of the hand and forearm muscles (in kilograms) (Tanita Handgrip Meter, RM40, East Malaysia). The test was carried out with the elbow fully extended and the forearm in a neutral position. At 1-minute intervals, three measurements were taken on the subjects' dominant side. The participants were instructed to told the handgrip of the device tightly for 3 seconds[30]. For statistical analysis, the highest scores from three measurements were taken. 1 day
Primary 1-Repetition Maximum Strength The indirect 1 repetition maximum (1RM) test is relatively simple, efficient, and safe when used and administered. The maximum repetition between 2 and 20 for any weight can be used to indirectly compute the 1RM value using the calculations. The formulas for calculating 1RM allow for weightlifting repetitions of less than 20 and a linear or curved relationship between the percentages of 1RMI. In order to determine the 1RM values of the study participants, indirect 1RM bench press, leg press, long pulley, leg extension, and overhead press were used. 1RM tests were performed using a weight machine (Technogym Selection 900). 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1